StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Brudom2002on Aug 08, 2020 5:46pm

140 Views

Post# 31383375

RE:Opinions and thoughts.

J'ai ce titre dans mon portefeuille depuis 5 ans (GEN) et depuis ce temps on pense que le titre va s'envoler, malhureusement le CEO, ne semble pas se soucier des actionnaires et est avare dans les nouvelles, j'ai toujours espoir mais s'il ne se passe rien dans le prochain trimestre, je passerai a d'autres choses

Bullboard Posts

POET increases production capacity to meet AI demand